AbCellera Biologics Inc. Common Shares (ABCL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for AbCellera Biologics Inc. Common Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$13.64
+6.31% today
Market cap
$4.2B
Overall quality
24/100
Kronos AI 30-day
−41.6%
0 of 8 simulated paths end higher
AbCellera Biologics Inc. Common Shares (ABCL) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $4.2B. It trades at $13.64, up 6.31% today. Its overall quality score is 24 out of 100, ranked against the whole US market. 10 analysts' average target of $16.78 implies +23.0% from today's price. Kronos AI's 30-day forecast is −41.6% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $16.78 |
| Low – high | $9.00 – $30.00 |
| Analysts | 10 |
| Upside to average | +23.0% |
Kronos AI 30-day forecast
| Expected close | $7.49 (−41.6%) |
| Likely range | −56.2% … −25.6% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 16 |
| Solvency | 52 |
| Growth | 4 |
| Overall | 24 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.